Megadose Methyl-Prednisolone (MDMP) for Autoimmune Hemolytic Anemia

Journal Title: Turkish Journal of Hematology - Year 2013, Vol 30, Issue 2

Abstract

To the Editor, Üsküdar Teke and colleagues originally used 1 mg kg–1 day–1 methylprednisolone (MDMP) for their patient with autoimmune hemolytic anemia without improvement, and after 3 weeks of steroid treatment splenic infarct developed.The patient was splenectomized but the hemolytic anemia again did not improve. Therefore, azathioprine was prescribed [1].

Authors and Affiliations

Şinasi Özsoylu

Keywords

Related Articles

The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients

Objective: The purpose of this study is to investigate the relationship between the CD56 and CD117 expressions and the clinical and laboratory findings in multiple myeloma (MM) patients. Materials and Methods: Analyses...

Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis

Objective: Transformed mycosis fungoides (T-MF) is a rare variant of MF with an aggressive course. In this study, we aimed to describe characteristics of MF/Sezary syndrome (SS) patients with transformation. Materials an...

Autoerythrocyte Sensitization Syndrome Treated with Kallikrein Inhibitor

To the Editor, I read the letter related to autoerythrocyte sensitization syndrome in a 7-year-old boy published in the Turkish Journal of Hematology [1]. I would like to remark on a few points that were not mentioned i...

Download PDF file
  • EP ID EP137501
  • DOI 10.4274/Tjh.2013.0052
  • Views 66
  • Downloads 0

How To Cite

Şinasi Özsoylu (2013). Megadose Methyl-Prednisolone (MDMP) for Autoimmune Hemolytic Anemia. Turkish Journal of Hematology, 30(2), 228-229. https://www.europub.co.uk/articles/-A-137501